Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India (HMIL), has reaffirmed its dedication to advancing cancer care through its flagship initiative, ‘Hyundai Hope for Cancer’. Developed in collaboration with the Indian Institute of Technology Madras (IIT Madras), the initiative was launched in September 2025 and has since achieved remarkable progress in research, prevention, and awareness, transforming thousands of lives across India.
At the core of the initiative lies the Hyundai Centre for Cancer Genomics at IIT Madras—home to India’s first community-based Cancer Tissue Biobank and the newly inaugurated Bharat Cancer Genome Atlas (BCGA). The BCGA is the country’s first open-access cancer genome database, designed to drive innovation in personalised oncology and enable faster breakthroughs in genomic-based cancer care.
Technology, Compassion, and Collaboration in Cancer Care
Puneet Anand, AVP & Vertical Head of Corporate Affairs, Communication & Social at HMIL, emphasized the foundation’s mission: “Hyundai Hope for Cancer reflects our firm belief that technology, compassion, and collaboration can bring about transformative change in cancer care. On National Cancer Awareness Day, we renew our commitment to ensuring that every citizen has access to timely, personalised, and dignified cancer treatment.”
With a total commitment of Rs 56 crore—including a Rs 3 crore Cancer Care Fund—HMIF continues to work towards equitable access to early detection, research, treatment, and community outreach. These efforts have already reached over 11,000 beneficiaries nationwide.
Key Milestones and Achievements
Community Outreach and Screening
Conducted 109 cancer awareness and screening camps across Tamil Nadu, reaching 11,095 individuals.
Early detection screenings covered oral, cervical, colon, breast, and prostate cancers.
448 individuals tested positive and were referred to government hospitals for further care.
Cancer Tissue Biobank and Genomic Sequencing
Collected 1,104 cancer tissue samples and completed whole genome sequencing for 528 paediatric leukaemia cases.
Genomic analysis continues to identify India-specific biomarker gene panels for early diagnosis and disease monitoring.
Launched the Bharat Cancer Genome Atlas (BCGA)—India’s first open-access cancer genome database hosted by IIT Madras.
HPV Vaccination Drive
Vaccinated 525 girls against Human Papillomavirus (HPV) in collaboration with Karkinos Healthcare and the Cancer Research and Relief Trust (CRRT) across Ariyalur, Virudhunagar, and Salem in Tamil Nadu.
Future Initiatives and Expansion Plans
The foundation plans to introduce free cancer treatment for underprivileged children in collaboration with leading healthcare institutions. Additionally, a technician training program will upskill over 100 laboratory professionals in genomic sequencing and molecular oncology by FY 2026.
A fully equipped Cancer Screening Vehicle has already covered 17 districts in Tamil Nadu, with plans to expand to Maharashtra and Haryana in FY 2026.
Over the next four years, HMIF aims to conduct 225+ awareness and screening camps across Tamil Nadu, Haryana, and Maharashtra, benefiting approximately 1.27 lakh individuals and vaccinating 5,000+ girls against HPV.
Continued Focus on Prevention and Awareness
By integrating research, community health outreach, and advanced genomic analysis, the Hyundai Hope for Cancer initiative continues to bridge the gap between technology and healthcare access. The program’s expansion—especially through free breast screening and preventive vaccination efforts—underscores HMIF’s vision for a healthier, cancer-aware India.
Related topics
